Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
AppFolio APPF beats Q1 2026 earnings estimates by 7 percent posts 197 percent revenue growth but shares still decline 2 percent PennantPark PFLT Stock Breaking Uptrend Slight Gain 20260415 BioVie BIVI Stock Undervalued Overhead Buying 20260418 Is Mangoceuticals MGRX stock near support HSIC Henry Schein delivers narrow Q4 2025 earnings beat shares tick higher on positive investor sentiment US Budget Airline Bankruptcy Restructuring Agreement Analysis DYOR Insight DPII points to accelerating AI client adoption as its primary future revenue growth driver Kaiser KALU Q1 2026 Earnings EPS 374 Beats Estimates What GigCapital8 GIWWRs 407 Jump Means for Investors 20260515 Elon Musk Faces Another Legal Setback as OpenAI Lawsuit Dismissed Angi ANGI Falls 106 Watching 486 Support 20260519 Why BranchOut BOF Just Dropped 539 What to Watch 20260518 Envirotech Vehicles EVTV Stock Up 486 Key Resistance at 272 20260519 Bond Market Signals Concern Over Fed Inflation Stance as Warsh Assumes Role Microsofts AI Adoption Reveals Costly Paradox Automation May Be More Expensive Than Human Labor SpaceXs IPO Prospects Highlight Heavy Reliance on Starlink for Growth and Profit Alphabet Inc Expands Gemini Enterprise Agent Marketplace Through Amdocs Partnership PB Fintech Cofounders Plan 6536 Crore Share Sale via Block Deal Form 144 Filing Signals Potential Insider Sale at PattersonUTI Energy ENVB Q4 2024 Earnings EPS Misses Estimates No Revenue Reported US Bancorp Q1 2026 Earnings EPS Beats Estimates Amid Stable Operations CVKD Q1 2026 Earnings NarrowerthanExpected Loss as PreRevenue Biotech Advances Pipeline DUO Q2 2021 Earnings Massive EPS Miss Sends Shares Lower ZBIO Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Amid PreRevenue Phase VRTS Q1 2026 Earnings Earnings Miss Estimates Amid Market Headwinds Stock Edges Higher CRISPR Therapeutics CRSP Edges Higher as GeneEditing Sector Regains Traction Gladstone Land LAND Edges Higher Breaking Down the Move Above 960 Greenwich LifeSciences GLSI Inches Higher Amid Calm Trading Session Acurx Pharmaceuticals ACXP Holds Near Key Support as Small Decline Signals Consolidation Nuveen New Jersey Municipal Fund NXJ Edges Higher as Yield Hunters Seek TaxAdvantaged Income